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Endorectal ultrasonography (ERUS) and magnetic resonance imaging (MRI) allow exploring the morphology of the
rectum in detail. Use of such data, especially assessment of the rectal wall, is an important tool for ascertaining the
perianal fistula localization as well as stage of the cancer and planning it appropriate treatment, as stage T3 tumors
are usually treated with neoadjuvant therapy, whereas T2 tumors are initially managed surgically. The only advantage
of ERUS over MRI is the possibility of assessing T1 tumors that could be treated by transanal endoscopic microsurgery.
However, MRI is better for visualizing most radiological prognostic features in rectal or anal cancer such as a
circumferential resection margin less than 1 mm, T stage at T1-T2 or T3 tumors with extramural extension less
than 5 mm, absence of extramural vascular invasion, N stage at N0/N1, and tumors located in the middle or upper third
of the rectum. It can also evaluate the intersphincteric space or levator ani muscle involvement. Increased signal on
diffusion weighted imaging (DWI) and low apparent diffusion coefficient (ADC) values as well as an irregular contour
and heterogeneous internal signal intensity seem to predict the involvement of pelvic lymphatic nodes better than
their size alone. Computed tomography as well as other examination techniques, including digital rectal examination,
contrast edema, recto- and colonoscopy, are less useful in staging of rectal cancer but still are very important screening
tools.
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The rectum, which is a terminal part of large intestine,
is anatomically divided into the anus, anal canal and am-
pulla. The last two parts are clinically separated into the
lower, middle and upper third [1,2]. The most inferiorly
located part is surrounded by the so-called sphincter
anal complex, formed by the smooth internal anal
muscle – the direct continuation of the circular layer of
the muscularis propria of the rectal ampulla and colon,
as well as the more superficially located striated external
anal sphincter and puborectal muscles, which belong to
the levator ani muscles. The lowest point of the external
anal sphincter indicates the upper anal margin (anal
verge), which is a principal landmark for all other rectal
measurements. The pectinate (dentate) line is located* Correspondence: fb3@wp.pl
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unless otherwise stated.1.5-2 cm upwards from the anus. It separates the anal
canal into anatomical and surgical parts located below
and above the line. The surgical canal (3–4 cm, shorter
in females) extends to the anorectal ring/junction, visible
at the level of the puborectal sling (lower margin of rec-
tal ampulla). The pectinate line is not visible in any
radiological examinations, but below it the inner layer of
the rectum is covered with modified skin with the squa-
mous epithelium (anoderm), while above it – like the
remaining infradiaphragmatic part of the digestive tract –
the mucosa is covered with columnar epithelium. The
junction between them is lined with a modified transi-
tional epithelium. It also has to be pointed out that the
anoderm is almost directly attached to the internal anal
sphincter, since the submucosal layer of connective tissue
does not exist on this level. Outside of the rectum, be-
tween the middle part of the organ and upper surface of
the levator ani, a loose connective tissue known as the
mesorectum is located. It contains lymph nodes and neu-
rovascular bundles as well as fat and fibrous tissue. It is. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ventrally by an upper continuation of the rectogenital
membrane (Denonvilliers’ fascia), which extends from the
dorsal surface of the prostate and seminal vesicle or fornix
of the vagina. In females and males this dense band forms
the rectovaginal septum and rectoprostatic fascia, respect-
ively. Laterally, a tiny but easily discernible structure
known as the mesorectal or perirectal visceral fascia is
seen [1,3]. It is worth mentioning that the volume of peri-
rectal fat is larger in males and positively correlates with
the visceral compartment area, but not with the age, body
cross-sectional area and body mass index [4] and, most
importantly, with staging of the rectal tumor [5]. The
mesorectal fat is limited superiorly by the peritoneum. Its
interior peritoneal reflection on the anterior rectal wall
forms the border between the middle and upper part of
the organ.
In spite of lack of submucosal connective tissue at the
level of the anatomical canal, like in the remaining parts
of the large and small intestine, the rectum has a multi-
layer wall that can be examined with both endorectal
(endoanal) ultrasonography and magnetic resonance im-
aging. Both techniques are helpful in establishing the
morphology of the rectum, most pathological lesions
and local staging of neoplasms. Computed tomography
as well as other examination techniques, including
digital rectal examination, contrast edema, and recto-
and colonoscopy, are less useful but still are very import-
ant screening tools (Table 1) [6].
Imaging modalities
Endorectal ultrasonography
Endorectal ultrasonography (ERUS), particularly with a
concomitant examination by the linear transducer, is
highly effective in most cases. It is usually performed
without any previous preparation, but an enema strongly
improves the image quality, especially when there are
stool residues in oncological patients [7].
The examination is performed in the left recumbent
(left decubitus, semiprone, Sims) or less frequently in
the knee-elbow position, which is preferred in patients
with sphincter insufficiency. Ultrasound is usually done
after digital rectal examination and proctoscopy, using a
mechanical or biplanar transducer with a frequency of
10 MHz or higher [7-14]. Some authors suggest using aTable 1 Algorithm of the pretreatment elective imaging work
Colon cancer Rectal
Biopsy during colonoscopy Diagnosis Biopsy
Abdominal CT or CT colonography Location MR
Abdominal CT T-stage MRI (s
Abdominal CT N-stage MR
Abdominal CT or liver MR chest CT or chest X-ray M-stage Abdom3D 16-MHz probe, which allows spatial analysis of both
the rectum and surrounding structures including mus-
cles and mesorectal fat. This system also permits archiv-
ing the full examination [8]. Higher frequencies give
better resolution of the rectal wall and sphincter com-
plex, while lower ones are helpful in a mesorectum
examination [15]. Due to the high cost, special water-
filled balloons are usually applied only in patients with
tumors located in the rectal ampulla (Figure 1). In such
cases, the balloon is filled with about 90 ml of water,
which compresses the lesion and removes the air from
the rectum [7].
Typically in ultrasound images five layers of the rectal
wall are visible: three hyper- and two hypoechoic ones
[7]. The inner hyperechoic layer represents the interface
between the probe/covering balloon and the mucosa.
The second layer – the hypoechoic one – indicates the
mucosa, muscularis mucosa and submucosa, which can-
not be differentiated sonographically. More superficially,
there is another hyperechoic line corresponding to the
interface between the submucosa and muscularis propria
(proper muscular layer of the rectum indicated by the
next hypoechoic line). The most external hyperechoic
line corresponds to the interface between the muscularis
propria and perirectal fat or visceral layer of the periton-
eum in the upper part of the ampulla [16]. Beynon et al.
[17] suggests that the mucosa and submucosa can be
distinguished, and the second layer (the hypoechoic one)
is formed exclusively by the mucosa and muscularis mu-
cosa, while the third hyperechoic line corresponds to the
submucosa.
Depending on the position of the probe, the surround-
ing muscles could also be seen. In the low third of the
rectum (at the level of the anal canal), usually the exter-
nal anal sphincter should be visible (Figure 2). Slightly
above it is replaced by the para-, recto- and prerectal fi-
bers of the levator ani, which at this level is formed by
the puborectal muscle. Between the puborectal sling and
caudally located external sphincter, there is an inter-
sphincteric plane filled with the lowest, tapered part of
the mesorectum [18]. This narrow layer is important in
planning any surgical procedures at the level of the anal
canal and for the staging of lower anal cancer. Moreover,
the muscle divides the anal canal into the upper and the
lower part. In front and slightly below the midrectalup for colon and rectal cancer [6]
cancer
and full colonoscopy
tage T1-T4, including evaluation of the mesorectal fascia), EURS (stage T1)
inal CT or liver MR chest CT or chest X-ray
Figure 1 Rectal endosonography with a water balloon. A tumor
limited to the mucosa, not invading the submucosa and muscularis
propria.
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superficial transverse perineal muscle. Above, the sem-
inal vesicles, prostate, urinary bladder, and urethra or va-
gina and uterus can also be observed in males and
females, respectively. Irrespective of gender, loops of the
small intestine and occasionally a low-positioned vermi-
form appendix may be seen as well [15].
In case of perianal fistulas, a hyperechoic contrast agent
(e.g., 3% hydrogen peroxide solution) injected directly into
the pathological canal is recommended [8]. However, typ-
ical intravenous sonographic contrast agents are seldom
used, mainly because of the high cost but also because of
the relatively short time required for picture acquisition.
The main limitation of ERUS application is tumors lo-
cated close to the sigmoid colon or infiltrating adjacent
organs. Moreover, it is a gold standard initial examin-
ation for fecal incontinence [13], but an anorectal man-
ometry is also recommended in such cases [19-23].
Magnetic resonance
Magnetic resonance imaging (MRI), with both endorec-
tal and pelvic phased array coils, is the gold standard, es-
pecially in oncological rectal examination. An endorectal
coil is a surface coil and provides very good images of
the wall of the organ, but offers limited information on
surrounding structures. Moreover, the best images are
taken only at the level of the coil. Its usefulness is also
limited because of the patient discomfort and in case of
anal stenosis. Rectal wall motion is also responsible for
the coil migration and misinterpretation of the observed
lesions. For these reasons phased array coils are recom-
mended in routine cancer staging. They obtain highersignal, but with wider coverage and improved homogen-
eity [24]. In rectal cancer, the pelvic coil showed high ac-
curacy in tumor (59-95%) and nodal metastasis
evaluation (39-95%). Similar data for the endorectal coil
reached 66–91 and 72-79%, respectively [25,26], and for
T staging was similar to ERUS [27,28]. However, it has
to be stressed that unlike for ultrasound, there are a
number of absolute and relative contraindications for
MRI (Table 2). The examination can be performed in
pregnant women, but without contrast media adminis-
tration and using a limited number of sequences [29,30].
The examination does not require any previous rectal
preparation but in some medical centers a prior enema
is recommended. Furthermore, the usage of intrarectal
water, ultrasound gel, gadolinium or air insufflations as
well as pretreatment with spasmolytic agents is debat-
able, but they may strongly improve image quality [2].
Most skeptics stress that any kind of artificial substances
inside the rectum may be uncomfortable to the patient
and, more importantly, may compress the mesorectal fat
and influence evaluation of the circumferential resection
margin. The main exception to the contrast enema is a
dynamic rectal examination, also known as MRI defeco-
graphy or proctography, performed for various pelvic
floor dysfunctions [31]. However, similar data, such as
for Park’s angle and various mobile rectal diameters,
could be obtained during ERUS and ultrasound examin-
ation of the perineum with a linear probe [7,13].
The rectal MRI examination is performed on 1.5-T or
higher systems, but the reported sensitivity and specifi-
city for 3 T are very similar to those obtained for 1.5 T.
However, due to the high signal, 3-T equipment may ob-
tain thinner T2-weighted images, which are the most
suitable for rectal evaluation [32].
During the examination, the patient has to be comfort-
ably positioned in a supine position, since image acquisi-
tion usually takes about 40–60 min. Like in most pelvic
examinations, breath holding is not recommended. After
initial coronal and sagittal localization images, usually a
sagittal T2-weighted, fast (turbo) spin-echo sequence is
performed. It is followed by large-field-of-view axial sec-
tions of the whole pelvis and T2-weighted thin-section
axial sections perpendicular to the long axis of the rec-
tum (Tables 3 and 4; Figures 3 and 4). In case of low rec-
tal cancers, high-spatial-resolution coronal imaging is
recommended just to see their position in relation to the
levator ani and sphincter complex [33]. It is especially
important in planning sphincter-sparing surgery [34]. In
perianal fistulas, small-field-of-view axial T2-weighted
sections seem to be more reasonable. Moreover, radial
water- and fat-saturation sequences are useful to obtain
spatial pseudo 3D reconstruction. Such MRI hydrography
has been previously used routinely to visualize the biliary
and pancreatic ducts (MRCP) and urinary pathways
Figure 2 Endosonographic morphology of the anal canal: a high
level (A) at the level of the sling of the puborectalis muscles (PR)
and superficial transverse perineal muscles (STP), mid level (B)
with a well-formed internal (IAS) and external anal sphincter
(EAS), and superficial/low level (C) with the external anal sphincter.
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medical centers the examination is performed accord-
ing to the suggestions of The Magnetic Resonance Im-
aging and Rectal Cancer European Equivalence Study
(MERCURY) [35]. Three-dimensional (3D) T2-weighted
sequences permit application of 1–2-mm-thin sections
with no intersection gap. They should be able to compen-
sate for difficulties with angulation of the tumor such as
tortuosity and redundancy of the rectum [18]. Usefulness
of the gadolinium contrast enhancement is debatable,
since it does not improve evaluation of local staging [36].
Moreover, since contrast enhancement requires fat sup-
pression, it results in reduction of the signal-to-noise ratio
and potential overstaging of the tumor due to enhance-
ment of adjacent nonmalignant structures such as the ves-
sels, desmoplastic stromal reaction and normal nodes
[24]. Unlike other authors, Zhang et al. [34] indicated that
3D fat-suppressed dynamic contrast enhancement is the
best technique to delineate the tumor margins. On the
other hand, contrast injection may be helpful in examin-
ation of the internal morphology of the tumor as well as
various perfusion values, which are important in the
evaluation of an early treatment response and in tumor
recurrence. For the same reason, diffusion-weighted im-
ages (DWIs) should be routinely performed, using increas-
ing b values (in our hospital usually 0, 50, 500 and 1,000 s/
mm2) (Figure 5). Even though the DWI images together
with ADC maps are very helpful in detection of the
lesions, they cannot be applied to confirm malignancy
without examination of classical T1- and T2-weighted se-
quences [37]. In both perfusion and ADC measurements,Table 2 Contraindications for magnetic resonance
imaging [30]
Absolute Relative
- Pacemaker - Pregnancy
- Cochlear implants - Claustrophobia
- Metallic object in the eye ball - Metal objects in soft tissues
- No verbal contact with patients
(deafness)
- Metal orthopedic treatment
elements






Table 3 Characteristics of standard sequences in MRI rectal examinations [24]
Philips Siemens General Electric
(Turbo spin echo) (Turbo spin echo) (Fast spin echo)
Repetition time (ms) 5,080 (sagittal) 3,000-6,000 4,000
4,018 (axial)
Echo time (ms) 132 (sagittal) 100 110
80 (axial)
No. of slices 23 (20 axial) 24 24
Thickness/gap 3 (sagittal) 5/0 5/0
5/1 (axial)
Interleaved No Yes NO
Echo train length 23 8 8
Matrix in phase direction 512 512 512
Matrix in frequency direction 370/70% (sagittal) 256 288
256/100% (axial)
Phase encoding direction AP AP AP
Field of view (mm) 250 250 250
Phase 250 240 250
Frequency 250 240 250
No. of acquisitions 3 (sagittal) 2 2
2 (axial)
Flow compensation Yes Yes Yes
Sat bands Anterior/superior Anterior Anterior
Table 4 Characteristics of standard sequences in MRI rectal examinations – continuation [24]
Philips Siemens General Electric
(Turbo spin echo) (Turbo spin echo) (Fast spin echo XL)
Repetition time (ms) 5,362 6,590 5,100
Echo time (ms) 100 136 85
No. of slices 16 24 28
Thickness/gap 3/0.3 3 3
Interleaved Yes Yes No
Echo train length 16 8 8
Matrix in phase encoding 256 256 256
Matrix in frequency encoding 256/90% 256 256
Phase encoding direction Foot to head Foot to head Superior inferior
Field of view (mm) 160 160 160
Rectangular field of view 100% 100% 160
Foldover Right to left Right to left No phase wrap
No. of acquisitions 6 4 4
Sat bands None Superior inferior Superior inferior
Scan duration (min:s) 7:35 7:36 8:40
Other No DRIVE No DRIVE Phase correct on
Prep phase auto Prep phase auto Flow camp on
Tailored radiofrequency fast
Burdan et al. European Journal of Medical Research  (2015) 20:4 Page 5 of 14
Figure 3 Anal cancer with invasion of the intersphincteric space, external anal sphincter (arrow) and metastasis in the inguinal lymph
node (arrowhead). Examination with a 1.5-T pelvic phased array coil. Axial T1- (A), T2- (C) and T1-weighted with fat suppression post-gadolinium-
enhanced images (D). Sagittal T2- (B) and T1-weighted images with fat suppression post-gadolinium-enhanced images (E).
Burdan et al. European Journal of Medical Research  (2015) 20:4 Page 6 of 14the region of interest (ROI) should only fit the patho-
logical lesion, without the neighboring tissues. Even ADC
measurement might be subjective; Attenberger et al. [38]
indicated that by using strict criteria they could be ana-
lyzed with good interobserver agreement in patients with
rectal cancer.From the clinical point of view, T2-weighted images
without fat saturation are the most helpful in distinguish-
ing normal morphology of the rectal wall from organ ab-
normalities. The most internal hyperintense layer is
formed by the mucosa and submucosa, which cannot be
differentiated by either MRI or ERUS. The next hypo- and
Figure 4 Rectal cancer with extramural extension in perirectal fat (arrow) and metastasis in a lymph node (arrowhead). Examination
with a 1.5-T pelvic phased array coil. Oblique T2- (A) and T1-weighted with fat suppression post-gadolinium-enhanced images (C). Sagittal T2- (B)
and T1-weighted with fat suppression post-gadolinium-enhanced images (D).
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perirectal fat, respectively. Usually, the mesorectal fascia
should be also detected as a low-signal line visible on the
margin of the mesorectum [2]. However, there are studies
in which five layers were clearly described. Stollfuss et al.
[39] were able to distinguish hypointense mucosa and
hyperintense submucosa in 19 of 24 post-resectionspecimens using T2-weighted images obtained on a
1.5-T system. The internally located circular-directed
muscular fibers had higher signal than the outer
longitudinal-directed fibers.
It is also important that MRI may differentiate mucin-
ous from nonmucinous adenocarcinomas [40,41] and may
be helpful in the identification of early recurrence from
Figure 5 Anal cancer (arrow) and metastasis in an inguinal lymph node (arrowhead) in the same patient as in Figure 3. Examination with a
1.5-T pelvic phased array coil. DWI images at b = 0 (A), 50 (B), 500 (C) and 1,000 s/mm2 (D) as well as the corresponding apparent diffusion coefficient
(ADC) map (E) at b = 1,000 s/mm2. The ADC value for the tumor and lymph node 0.867 × 10−3 and 0.809 × 10−3 mm2/s, respectively.
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[11,12]. Moreover, unlike CT, MRI does not use ionizing
radiation and highly nephrotoxic contrasts.
Description of rectal lesions in ERUS and MR
In the final radiological report, any abnormalities should
be identified and clearly described. In both malignant
and nonmalignant rectal lesions various calcifications
have been found. Anatomically or for general descrip-
tion, rectal lesions, like the organ itself – as described in
detail in the introduction – may be divided into lower,
middle and upper ones. However, in clinical practice, theParks [8,12] and WHO TNM classifications are com-
monly used (Table 5) [42]. The former describes four
primary types of perianal fistulas: intersphincteric, trans-
sphincteric, suprasphincteric and extrasphincteric. The
latter is used for tumor staging and helps to divide pa-
tients for surgery (stage T1 and T2) or for preoperative
therapy (>T2). Nowadays, patients with T1 stage undergo
transanal endoscopic microsurgery, while those with
stages T2 and T3 are usually treated with a total mesorec-
tal excision, without or after preoperative neoadjuvant
therapy (radio- or radiochemotherapy), respectively. Such
a therapeutic schema highly increases the 5-year survival
Table 5 TNM staging principles for the most common rectal neoplasms: anal (anal canal) and rectal (ampulla)
carcinoma, carcinoid and gastrointestinal stromal tumors (GIST) according to the current classification of International
Agency for Research on Cancer/World Health Organization [42]
Anal carcinoma Rectal carcinoma Carcinoid of the rectum GIST
T Primary tumor








Tis Carcinoma in situ, Bowen disease, high-grade
squamous interepithelial lesion (HSIL), anal
interepithelial neoplasia II-III (AIN II-III)
Carcinoma in situ: intraepithelial or invasion
of lamina propria
T1 Tumor 2 cm or less in the greatest
dimension
Tumor invades submucosa Tumor invades lamina
propria or submucosa and
is no greater than 2 cm in
size
Tumor 2 cm or less
in greater dimension
T1a – tumor less than
1 cm in size
T1b – tumor 1 to 2 cm
in size
T2 Tumor more than 2 cm but not more than
5 cm in the greatest dimension
Tumor invades muscularis propria Tumor invades muscularis
propria or is greater than
2 cm in size
Tumor more than
2 cm but not more
than 5 cm
T3 Tumor more than 5 cm in the greatest
dimension






5 cm but not more
than 10 cm
T4 Tumor of any size invades adjacent organ(s),
e.g., vagina, urethra, bladder (direct invasion
of rectal wall, perianal skin, subcutaneous
tissue or the sphincter muscle(s) alone is
not classified as T4)
Tumor perforates visceral peritoneum (T4a)






10 cm in the
greatest dimension
N Regional lymph nodes













N1a - Metastasis in 1 regional lymph node
N1b – Metastasis in 2 to 3 regional lymph
nodes
N1c Tumor deposit(s), i.e. satellites, in the
subserosa or in non-peritonalized pericolic or
perirectal soft tissue without regional lymph
node metastasis
N2 Metastasis in unilateral internal iliac
and/or inguinal lymph nodes
Metastasis in 4 or more regional lymph
nodes
N2a - metastasis in 4 to 6 more regional
lymph nodes
N2a - metastasis in 7 or more regional
lymph nodes
N3 Metastasis in perirectal and inguinal lymph
nodes and/or bilateral internal iliac and/or
bilateral inguinal lymph nodes
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Table 5 TNM staging principles for the most common rectal neoplasms: anal (anal canal) and rectal (ampulla)
carcinoma, carcinoid and gastrointestinal stromal tumors (GIST) according to the current classification of International
Agency for Research on Cancer/World Health Organization [42] (Continued)
M Distal metastasis
M0 No distal metastasis No distal metastasis No distal metastasis No distal metastasis
M1 Distal metastasis Distal metastasis Distal metastasis Distal metastasis
M1a – metastasis confined to one organ
M1b – metastasis in more than one
organ or the peritoneum
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patients with preoperative neoadjuvant therapy had a sub-
stantially lower rate of local recurrence compared with
those who received similar postoperative treatment [43].
On the other hand, low rectal tumors form a distinct en-
tity among all neoplasms of the organ as they have a high
risk of local recurrence and poor outcome compared to le-
sions located in the middle and upper rectum [44]. It is es-
pecially important in the abdominoperineal excision,
which is characterized by a relatively high risk of local re-
currence (>30%) [35].
In nonmalignant lesions ERUS offers similar accuracy
to MRI and could be easily applied in all pathologies lo-
cated close to the rectal wall. Due to the higher spatial
resolution, it is even better than MRI in differentiating
T1 (T1sm1 and T1sm2) and T2 tumors, but is more
subjective and depends highly on the sonographer’s ex-
perience [45]. In contrast, MRI is more reproducible and
allows accurate evaluation of neoplastic and distal
spread, including measurement of mesorectal involve-
ment and establishing the potential surgical circumfer-
ential resection margin. According to Wieder et al. [46],
MRI led to accurate prediction of the circumferential re-
section margin with 100% sensitivity and 88% specificity,
which depend on the minimum distance of the tumor to
the mesorectal fascia seen in histological examinations.
It is also a method of choice to exclude infiltration of
structures located nearby, but in such an examination
the gadolinium contrast enhancement strongly increases
the accuracy [18,46,47]. The main problem with MRI is
an overstaging usually caused by a desmoplastic reaction
in nonneoplastic structures located close to the tumor
margin [47]. It usually happens in case of stage T2 and
T3. However, in stage T3 the muscularis propria signal
intensity is unclear, while its external margin losesTable 6 Extramural vascular invasion scoring system by Smith
Score 1 Tumor extension through the muscle layer is not nodular, lack
Score 2 Minimal extramural stranding/nodular extension, but not in the
Score 3 Extramural vessels adjusted to the tumor, but these vessels are
Score 4 Intermediate signal intensity apparent within the vessels, altho
Score 5 Obvious irregular vessel contour or nodular expansion of the vsmoothness and becomes more nodular or spiculated.
On the other hand, hyperplasia of the muscularis propria
is associated with radiation and may also increase over-
interpretation [39]. It is worth mentioning that com-
puted tomography (CT) is not indicated in anal tumor
diagnosis because of low sensitivity (66%) [48,49].
Irrespective of the applied method for each tumor, cli-
nicians require the following information: tumor spread,
including detailed evaluation of the mesorectal fascia (T
feature) and extramural venous invasion, lymph node in-
volvement (N feature) and presence of distal metastases
(M feature). However, in case of rectal abnormalities the
distance from the sphincter anal complex as well as the
sphincters’ morphology and their function are also im-
portant because a low rectal tumor without any sphinc-
ter invasion and a distance between its inferior pole and
the upper margin of the internal sphincter may be
treated with low anterior resection consisting of en-bloc
resection of the rectum with total mesorectal excision
[18]. If possible, the distance to the mesorectal fascia or
levator ani muscles for low rectal tumors should also be
established. From a clinical point of view, it is more im-
portant to measure the depth of extramural spread in
the mesorectal fat than to ascertain the T stage, since a
T2 tumor has the same prognosis as a T3 tumor with
less than 1 mm spread. Moreover, T3 tumors with less
and more than 5 mm mesorectal invasion have different
5-year survival rates, i.e., 85 and 54%, respectively
[50,51]. According to Beets-Tan et al. [52], perirectal
spread terminating at least 5 mm from the fascia pre-
dicts an uninvolved circumferential margin of 1 mm at
histological analysis with 97% confidence. However, such
measurement is difficult and imprecise in tumors lo-
cated in a lower third of the anal canal, on its anterior
wall or in patients with a small amount of perirectal fatet al. [59]
of vessels adjacent to areas of tumor penetration
vicinity of any vessels
of normal caliber, and there is no definite tumor signal within the vessel
ugh the contour and caliber of these vessels are only slightly expanded
essel by definite tumor signal
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and crucial for therapeutic management.
Extramural venous invasion – beyond the muscularis
propria in an endothelium-lined vessel – is important
since neoplastic cell embolism in the portal circulation
may initiate distant metastases through hematogenous
spread [53]. It is associated with a higher incidence of
local and distant metastases as well as poorer overall
survival rates [54,55]. Such complications were observed
histopathologically in 10-54% cases of rectal cancer [56],
but could be also evaluated by MRI but not CT [57]. A
recent report [58] states that patients with MRI-detected
venous invasion had a 3.7 times increased relative risk of
metachronous metastatic disease. The most common
system (Table 6) applied for such evaluations was intro-
duced by Smith et al. [59] and divides the tumors into
lesions without (score 0–2) and with venous invasion
(score 3–4). Additionally, each vessel should be de-
scribed as a small (a perforating vein that runs perpen-
dicular to the rectal lumen), medium (an unnamed vein
that runs parallel to the rectal lumen) or large named
vein [58]. It is worth mentioning that in extramural ven-
ous invasion an abdominal MRI follow-up is recom-
mended, since according to Scharitzer at al. [60], a
gadoxetic-acid-enhanced 3-T system is more sensitive
than 64-row multidetector CT in the detection of small
(≤10 mm) hepatic metastases. On the other hand, MRI’s
usefulness, especially in minute lesions, is limited by
various artifacts related to the patient’s condition (e.g.,
respiratory and cardiac motion, vascular pulsation,
nearby located small cysts, liver steatosis and iron accu-
mulation, etc.) as well as artifacts and pitfalls related to
the scanner and/or magnetic elements inside of the ex-
amined patient (i.e., aliasing, black boundary, chemical
shift, entry slice phenomenon, Gibbs energy, magnetic
susceptibility, moiré fringes, RF overflow, shading, slice-
overlap, susceptibility, zebra stripes, zippers) [30,61,62].
This examination technique is also limited because of its
cost and insufficient availability in many institutions.
However, according to the algorithm of the European
Registration of Cancer Care (EURECCA) [6], the M sta-
ging includes MRI or CT examination of the abdomen
(Table 1). Furthermore, for detailed lung evaluation only
CT is recommended [63]. The usefulness of PET-CT is
limited only to multivisceral metastases and differentiat-
ing between fibrosis and tumor, particularly in locally re-
current rectal cancer. However, in such cases the DWI
significantly improves the diagnosis [64].
Nowadays, the main problem in rectal cancer staging
is evaluation of lymphatic spread. The difficulty lies in
the lack of proper radiological criteria for nodal meta-
static changes in the pelvis and various lymphatic path-
ways that carry the lymph from the rectum [1]. The
lymph from the upper part of the ampulla is usuallydrained via pararectal lymph nodes located on the mus-
cularis propria, either through sacral lymph nodes or
directly into inferior mesenteric lymph nodes along the
inferior rectal vessels. The remaining part of the rectum
over the pectinate line drains the lymph directly to the
sacral lymph nodes or via vessels surrounding the mid-
dle rectal artery into the internal iliac lymph nodes. All
those nodes may not be visible in physiological condi-
tions in ERUS and MR. The inferior third of the rectum,
below the pectinate line, sends the lymph into the hori-
zontal part of the superficial lymph nodes that are
clearly visible in most radiological procedures.
For the evaluation of lymphatic spread, a pelvic phased
array coil is recommended. Like CT, it gives an oppor-
tunity to examine most regional lymph nodes [6,35].
Discrimination between normal and metastatic lymph
nodes by MRI remains problematic. For a very long
time, the CT criteria that stress the lack of an oval shape
and fatty sinus, round or irregular margin, as well as
short transversal diameter over 10 mm, were applied to
MR. However, while using such criteria, the reported ac-
curacy was relatively low and reached only 43-85% [65].
Some authors described even lower thresholds for para-
rectal lymph nodes, but the sensitivity, specificity and
accuracy in lymph node metastases with diameters
greater than 6 mm were only 57, 88 and 76%, respect-
ively [66]. Using a 5-mm short axis as a threshold re-
sulted in lower sensitivity (66%) and specificity (76%)
[67]. Currently, there is a tendency to report any pelvic
lymph nodes since their transversal diameters have not
been established in any large and multicenter studies.
The irregular borders and signal intensity are principle
features in node metastasis and allow much higher sen-
sitivity (85-95%) and specificity (95-97%) [68]. Now-
adays, according to the EURECCA principles, nodes
>3 mm can be characterized as malignant or benign by
signal and border features [6]. On high-resolution MR,
identification of nodes <3 mm in diameter containing
metastatic foci remains a challenge. Furthermore, most
publications stress that the presence of ≥4 lymph nodes
is associated with a higher risk of local recurrence [69].
However, based on new clinical observations [70,71], a
well-preformed total mesorectal excision limiting nodal
involvement is no longer a risk factor for a local recur-
rence. On the other hand, identification of involved
lymph nodes located outside of the mesorectal fascia is
important, as they will not be removed during a stand-
ard anterior rectal resection with total mesorectal exci-
sion [18]. Such nodes may require additional treatment
since they are responsible for local recurrence.
In a problematic situation, high signal in DWI and low
on ADC maps, as well as low ADC values, could also be
helpful, since in metastatic infiltration similar features
are seen for the tumor and nodes. However, the main
Burdan et al. European Journal of Medical Research  (2015) 20:4 Page 12 of 14limitation of the method is the relatively large size of the
ROI (≥1 cm2) and at least three or four different b values
used during the acquisition of the DWI sequence [30].
Attenberger et al. [38] found that ADC measurements
and functional parameters were useful in differentiating
N stages. However, Mizukami et al. [72] reported a high
negative predictive value of DWI; even positive nodes
had at least 1-cm diameter in the short axis. Promising
data came from studies with new contrast agents (i.e.,
ferumoxtran-10, USPIO), but they are not routinely ap-
plied in clinical practice, and most of them are not regis-
tered for daily radiological practice [73,74]. Moreover,
Lambregts et al. [75] introduced a novel method utiliz-
ing gadofosveset enhancement to assess chemical-shift
artifacts associated with lymph node involvement, but
data have not been confirmed in a multicenter study.
On the other hand, it has to be pointed out that Bipat
et al. [76] indicated that in lymph node involvement and
organ invasion, the estimated sensitivity and specificity
of ERUS, MRI and CT were similar. However, in muscu-
laris propria invasion, ERUS and MRI imaging had simi-
lar sensitivities, but the specificity of sonography was
significantly higher (86 vs. 69%). Similar data were estab-
lished for mesorectal invasion. The sensitivity of ERUS
(90%) was higher than for CT (79%) and MRI (82%),
while the specificities were comparable. In nodal meta-
static spreading, the opposite data were recently pre-
sented by Puli et al. [77], who concluded that the lower
accuracy of EURS in comparison to MRI and CT is due
to lack of visualization of the entire mesorectum.
Conclusion
Endorectal ultrasonography (ERUS) and magnetic reson-
ance imaging (MRI) have become the state of the art in
radiological examination of the terminal part of the digest-
ive tract. Both techniques allow a detailed evaluation of
the multilayer wall of the rectum, which is obligatory in
ascertaining the stage of the rectal and anal cancer and
therapeutic strategy, as tumors in stage T2 and T3/T4 are
usually treated surgically or with neoadjuvant therapy, re-
spectively. The only advantage of ERUS over MRI is the
possibility of assessing T1 tumors that could be managed
by transanal endoscopic microsurgery. However, MRI is
more precise in visualizing the perirectal fat, mesorectal
fascia and peritoneal involvement, extramural venous in-
vasion as well as surrounding organ infiltration. It may
also evaluate an involvement of the intersphincteric space
or levator ani muscles. In spite of well-established criteria
for local tumor spreading, there are no proper principles
for lymph node involvement. Increased signal on DWI
and low ADC values as well as irregular contour and het-
erogeneous internal signal intensity seem to predict the
involvement of pelvic lymphatic nodes better than their
size alone. Because of the lack of any radiologicalprinciples for pelvic nodular spreading, the European
Registration of Cancer Care suggests relying on MRI for
the T-substage, mesorectal fascial involvement and extra-
mural vascular invasion, as nodal staging is less effective.
Based on all the presented data, the following are good
prognostic features in rectal cancer: the tumor has a cir-
cumferential resection margin less than 1 mm, T stage at
T1-T2 or T3 tumors with extramural extension less than
5 mm, absence of extramural vascular invasion, N stage at
N0/N1, and tumors located in the middle or upper third
of the organ. In low rectal tumors, the lack of compromis-
ing of the intersphincteric space or levator ani muscles
was also described [18].
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